The Oxford Nanopore PromethION devices enable high-output, high-throughput sequencing of native DNA or RNA samples on demand. PromethION 24 (P24) and PromethION 48 (P48), operating up to 24 or 48 flow ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore) today announces a collaboration with 10x Genomics, to enable a streamlined workflow for sequencing full-length ...
Oxford Nanopore Technologies is rolling out a new version of its high-throughput benchtop DNA sequencer with the goal of providing genetic data to a wide variety of researchers and scientific areas.
The PromethION-24 from ONT provides unparalleled flexibility in performing long-read sequencing across a wide range of sample types. By allowing up to 24 independent, simultaneous flow cell sequencing ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies Ltd, the company behind the only portable real-time DNA/RNA sequencer, MinION, has raised £100M ($140M) in new investment. Funds were ...
Oxford Nanopore Technologies is looking forward to “the year of the proteome,” as co-founder and CEO Gordon Sanghera, PhD, labeled 2025 during his presentation at the recent 43rd Annual J.P. Morgan ...
See how cancer research can benefit from accessible, targeted long nanopore reads which facilitate a comprehensive analysis of multiple variant types across genomics, transcriptomics, and epigenetics.
Detailed price information for Oxford Nanopore Tech Plc (ONTTF) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results